Multiple negative elements contribute to repression of the HOX11 proto-oncogene

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• The HOX11 proto-oncogene is crucial for spleen development during embryogenesis.
• In adult tissues, HOX11 expression is silenced, but its aberrant expression is linked to T-cell acute lymphoblastic leukemia (T-ALL).
• Chromosomal translocations involving T-cell receptor (TCR) genes often activate HOX11 in T-ALL, but alternative mechanisms exist.

Purpose of the Study:

• To investigate the mechanism of HOX11 repression in normal hematopoietic cells.
• To identify negative regulatory elements in the human HOX11 promoter responsible for silencing gene expression.
• To explore potential alternative activation mechanisms of HOX11 in leukemia.

Main Methods:

• Sequencing of over 4.5 kilobases of DNA upstream of the human HOX11 gene.
• Transfection assays using reporter genes to test promoter activity.
• Comparative sequence analysis of human and mouse HOX11/Hox11 promoters.

Main Results:

• Identified four negative regulatory elements (NREs) in the HOX11 promoter.
• Two NREs (NRE2, NRE4) showed cell-wide function; two (NRE1, NRE3) were cell-type specific.
• Sequence conservation of three NREs between human and mouse promoters suggests functional importance.

Conclusions:

• A model is proposed where multiple negative elements collectively repress HOX11 expression in normal blood cells.
• Disruption or mutation of these NREs may contribute to the aberrant HOX11 expression observed in T-ALL and erythroleukemia.
• Understanding these regulatory mechanisms could offer insights into leukemia development.